Fierce Pharma

MAY 14, 2024

It’s been a long wait for Ascendis Pharma to score FDA approval for its hormone replacement therapy TransCon PTH (palopegteriparatide). It’s been a long wait for Ascendis Pharma to score FDA approval for its hormone replacement therapy TransCon PTH (palopegteriparatide).

Hormones 122

Hormones FDA Approval Regulation 122

STAT News

JANUARY 18, 2023

Trans and nonbinary teenagers who receive gender-affirming hormones experience less depression and anxiety and more satisfaction with life than before the treatment, according to a new study published Wednesday in the New England Journal of Medicine. for two years after initiating hormone treatment. Read the rest…

Hormones 126

Hormones Medicine Research Drugs 126

STAT News

MARCH 21, 2023

Pills, patches, implants, and injections — the various forms of hormonal birth control have different formulations and doses of estrogen, progestin, or both. The analysis found that most forms of hormonal birth control, regardless of their formulation, seem to confer roughly the same, small increase to breast cancer risk.

Hormones 124

Hormones Medicine Research 124

Fierce Pharma

MAY 1, 2023

Pfizer, Astellas build case for Xtandi in early-stage hormone-sensitive prostate cancer aliu Mon, 05/01/2023 - 09:56

Hormones 118

Hormones 118

XTalks

OCTOBER 23, 2024

Mira, a California-based women’s health technology company, has introduced its Menopause Transitions Kit, a new hormone monitoring kit designed for menopausal women. The at-home device enables women to track key hormone levels, offering real-time insights into the complex hormonal fluctuations associated with perimenopause and menopause.

Hormones 100

Hormones Production Marketing Manufacturing 100

Medical Xpress

MAY 14, 2023

A new review published in the Canadian Medical Association Journal (CMAJ ) recommends menopausal hormone therapy, historically known as hormone replacement therapy (HRT), as first-line treatment in people without risk factors.

Hormones 94

Hormones Production 94

Scienmag

MARCH 22, 2022

The stress hormone cortisol reduces altruistic behavior and alters activity in brain regions linked to social decision making — but only in people who are better at imagining others’ mental states, according to new research published in JNeurosci. The stress hormone cortisol reduces altruistic behavior and alters activity in […].

Hormones 92

Hormones Research 92

Bio Pharma Dive

MARCH 6, 2023

A yearslong regulatory battle over the hormonal shot Makena is approaching its end, with consequences for both preterm birth prevention and the agency’s authority to withdraw drugs shown to be ineffective in follow-up testing.

Hormones 264

Hormones Drugs 264

Pharmaceutical Technology

FEBRUARY 9, 2023

Ibutamoren mesylate is under clinical development by Lumos Pharma and currently in Phase II for Growth Hormone Deficiency. According to GlobalData, Phase II drugs for Growth Hormone Deficiency have a 63% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. It is administered orally.

Hormones 100

Hormones Drugs Clinical Trials Clinical Trials 100

Scienmag

JUNE 27, 2022

Hormone therapy is successful at keeping metastatic prostate cancer under control, but eventually the tumor cells become resistant to it. Credit: Netherlands Cancer Institute Hormone therapy is successful at keeping metastatic […].

Hormones 91

Hormones Protein Regulation Medicine 91

Medical Xpress

NOVEMBER 7, 2022

Researchers have discovered the vital role of a hormone, which develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

Hormones 98

Hormones Development Research 98

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 9, 2024

Now two new studies raise the possibility of complex interactions between hormones and […] In the US, roughly two out of every three people with Alzheimer’s is a woman, a statistic that could be partially explained by the fact women typically live longer than men. Yet researchers have suspected there could be more to the story.

Hormones 246

Hormones Research Clinical Trials Clinical Trials 246

Pharmaceutical Technology

MARCH 17, 2023

Ghryvelin is used for the diagnosis of Adult Growth Hormone Deficiency (AGHD), a rare and serious condition, as well as for Childhood Onset Growth Hormone Deficiency (CGHD), if approved. Macimorelin is marketed under the brand name Ghryvelin in the EEA and the UK.

Hormones 263

Hormones Licensing Licensing Medicine 263

Medical Xpress

JANUARY 27, 2023

Turning a decades-old dogma on its head, new research from scientists at UC San Francisco and Stanford Medicine shows that the receptor for oxytocin, a hormone considered essential to forming social bonds, may not play the critical role that scientists have assigned to it for the past 30 years.

Hormones 106

Hormones Scientist Medicine Research 106

NPR Health - Shots

JANUARY 27, 2023

The hormone oxytocin plays a key role in long-term relationships. But a study of prairie voles finds that the animals mate for life even without help from the "love hormone." Image credit: Nastacia Goodwin)

Hormones 98

Hormones 98

Medical Xpress

MAY 8, 2023

A new study suggests that various types of hormone therapies not only increase lumbar spine bone mineral density (BMD) in postmenopausal women but also protect against bone loss, even after hormones have been discontinued. Study results are published online in Menopause.

Hormones 98

Hormones Gerontology 98

Pharma Times

NOVEMBER 24, 2021

The leading UK preganancy and baby loss charity Tommy’s have said with the approval of the hormonal drug, as many as 8,450 miscarrages a year could be prevented.

Hormones 101

Hormones Drugs 101

Outsourcing Pharma

JULY 11, 2024

In an exclusive interview, Akash Bakshi, CEO of YourChoice Therapeutics, delves into the inspiration and journey behind developing a hormone-free birth control pill for men.

Hormones 94

Hormones Development Clinical Development 94

Medical Xpress

APRIL 20, 2023

But whether endocrine hormones also play an important role in brain-bone talk has been unclear. Bones are not stagnant structures. According to recent studies, bones maintain a lively metabolism and closely interact via nerves with the brain.

Hormones 98

Hormones 98

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 24, 2024

The constant ebb and flow of hormones that guide the menstrual cycle don’t just affect reproductive anatomy. They also reshape the brain, and a study has given us insight into how this happens.

Scientist 237

Scientist Hormones Research Clinical Trials 237

Medical Xpress

NOVEMBER 15, 2022

Reproductive health experts consider hormonal contraceptives good choices for adolescents because they're safe and highly effective at preventing pregnancy, but one aspect of their effect on the teenage body remains a mystery—whether and how they modify the developing brain.

Hormones 98

Hormones Development 98

Medical Xpress

MAY 12, 2023

High levels of the stress hormone cortisol during the third trimester of pregnancy may improve speech and language skills in the first three years of a child's life, according to research to be presented May 13 at the 25th European Congress of Endocrinology in Istanbul.

Hormones 98

Hormones Development Research 98

Medical Xpress

JANUARY 18, 2023

Transgender and nonbinary youth experienced significant improvement in appearance congruence (or the degree to which physical characteristics align with gender) and sustained improvements in depression and anxiety over two years after starting treatment with gender-affirming hormones, according to a multicenter U.S.

Hormones 98

Hormones Medicine 98

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 17, 2023

New research by our team has identified sensitivity to a hormone made in abundance by the developing pregnancy, GDF15, […] Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

Hormones 246

Hormones Research Development Clinical Trials 246

Fierce Pharma

JUNE 28, 2023

With a blessing Wednesday for once-weekly growth hormone deficiency (GHD) drug Ngenla, the New York pharma giant has racked up four approvals from the agency over the last five weeks. Pfizer is on an FDA heater. Pfizer is on an FDA heater.

Hormones 97

Hormones Drugs 97

Bio Pharma Dive

MAY 29, 2024

The Series B funding from Two Sigma Ventures, RA Capital and others will help Gameto develop technology it says could replace hormonal injections and shorten the IVF process.

Hormones 200

Hormones Development 200

STAT News

AUGUST 8, 2022

Aldosterone, a hormone produced by the triangular adrenal glands, might be the key target.    In the observational study, researchers analyzed health data from 3,680 people with chronic kidney disease for nearly 10 years.

Hormones 98

Hormones Research Development Drugs 98

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 9, 2022

Millions around the world must inject the crucial hormone underneath their skin several times a day to keep their glucose levels in balance. The most effective way for people with diabetes to deliver insulin is also incredibly intrusive.

Insulin 240

Insulin Hormones Scientist Clinical Trials 240

Scienmag

JULY 7, 2022

CLEVELAND, Ohio (July 7, 2022)—In the 20 years since the Women’s Health Initiative, hormone therapy remains one of the most hotly debated topics around the treatment of such bothersome menopause symptoms as hot flashes.

Hormones 90

Hormones 90

Pharmaceutical Technology

MAY 15, 2023

Prior to Veozah’s approval, available treatments for hot flashes included hormone replacement therapy, which consisted of either combined oestrogen and progestogen or oestrogen. However, the use of hormone replacement therapy comes with its set of challenges. This was done to allow for more time for the application’s review.

Hormones 244

Hormones FDA Approval Licensing Licensing 244

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 17, 2023

The pill, called Opill – the brand name for the tablet formulation of norgestrel – is an oral contraceptive containing only progestin hormone, which helps prevent pregnancy […]

Hormones 230

Hormones Containment Branding Drugs 230

Pharmaceutical Technology

NOVEMBER 21, 2023

Despite a US FDA rejection for the drug earlier this year, the European Commission has approved Yorvipath for chronic hypoparathyroidism.

Hormones 130

Hormones Drugs 130

Medical Xpress

APRIL 13, 2023

The dosage of hormones in common contraceptives could be reduced by as much as 92% and still effectively suppress ovulation, according to a computational model described this week in PLoS Computational Biology by Brenda Lyn A. Gavina, Ph.D. student at the University of the Philippines Diliman, and her collaborators.

Hormones 75

Hormones 75

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 23, 2024

Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger. Drugs like Ozempic are very effective at helping most people who take them lose weight. But does weight come back when you stop using […]

Doctor 185

Doctor Doctors Hormones Drugs 185

BioSpace

JUNE 27, 2023

Overcoming an FDA rejection in January 2022, Pfizer and OPKO’s Ngenla will provide a long-acting, reduced-frequency treatment option for children with growth hormone deficiency.

Hormones 75

Hormones Drugs 75

Pharmaceutical Technology

JULY 13, 2022

Orion discovered and developed ODM-208 to treat hormone-dependent cancers, such as prostate cancer. Merck Research Laboratories president Dr Dean Li said: “Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer. “We

Development 264

Development Hormones Production Marketing 264

Medical Xpress

APRIL 3, 2023

A new study, led by Mass General Brigham researchers, sheds light on the relationship between the risk of Alzheimer's disease and age of menopause and use of hormone therapy (HT). Women are more likely than men to develop Alzheimer's disease (AD), with women making up two-thirds of the population living with AD.

Hormones 81

Hormones Development Research 81